Doing Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Emergency use for the vaccine for kids under 12 has been so long delayed? >> well, you know, chuck, i think it comes down to the importance of having really good information. the younger you are, thankfully, the less likely you are to have severe disease, to be hospitalized and to die. and if you want the fda to approve the authorization of these vaccines for kids, if you want the advisory committee and the cdc to recommend them, you're really going to have to show that they're incredibly safe and that they're effective. it's much harder doing studies in really young kids. you can have a child...

To get under the veil of protection of a vaccine. right now, we, at the nih, the companies are all doing studies to do what we call age deescalation. looking at 11 to 9, 9 to 6, 6 to 2. and then, six months to two years, we're collecting safety data and we're collecting immunogenicity data. we're going to have enough data where the companies will be able to present the data to the cdc by the mid-fall or so. somewhere around september or octob october for pfizer. a little bit later for moderna. the fda then has the task, which they did so well now with the bla, of looking at the data and making...

Appropriately is what about 11 down to 5 and even lower, namely the elementary school kids who everyone really wants to get under the veil of protection of a vaccine. right now we at the nih, the companies are all doing studies to do what we all age de-escalation, looking at 11 to 9, 9 to 6, 6 to 2, and then 6 months to 2 years. we're collecting safety data and we're collecting immunogenicity data. we'll have enough data to present to the cdc by mid-fall or so, september, october, for pfizer. a little later for moderna. the fda has the task, which they did so bell now with the bla of looking a...